Sign In
Buy AUPH
$15.67
+0.280 (+1.82%)
At Close: Jun 03, 2026
Aurinia to Participate in Upcoming Investor Healthcare Conferences
06:00am, Tuesday, 02'nd Jul 2024
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia to Participate in Upcoming Investor Healthcare Conferences.
Strength Seen in Aurinia (AUPH): Can Its 5.6% Jump Turn into More Strength?
05:50am, Monday, 17'th Jun 2024
Aurinia (AUPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
Aurinia Announces 2024 Annual General Meeting Results
12:16pm, Friday, 14'th Jun 2024
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Announces 2024 Annual General Meeting Results.
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), today announced an oral presentation at the European Alliance of Associations
Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce
05:30pm, Tuesday, 04'th Jun 2024
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce.
Aurinia Provides Update on Proxy Statement
06:30pm, Monday, 03'rd Jun 2024
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Provides Update on Proxy Statement.
3 Biotech Names Under $10 I Own
10:18am, Sunday, 02'nd Jun 2024
Today, we take a look at three promising biotech names that currently trade under $10 a share. Two of these are quickly moving towards profitability, and the other is cash rich and has several partner
Aurinia Will Attend 2024 Jefferies Global Healthcare Conference
06:00am, Thursday, 30'th May 2024
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Will Attend 2024 Jefferies Global Healthcare Conference.
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), today announced the presentation of results from an updated cost-effective an
How Much Upside is Left in Aurinia (AUPH)? Wall Street Analysts Think 96.51%
11:01am, Tuesday, 07'th May 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 96.5% in Aurinia (AUPH). While the effectiveness of this highly sought-after metric is questionable, the positi
Aurinia Pharmaceuticals Shareholder Urges Board of Directors to Take Action to Enhance Shareholder Value
09:00am, Tuesday, 07'th May 2024
GENEVA--(BUSINESS WIRE)--Lucien Selce, who owns approximately 2.2% of the outstanding shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”), today issued the follo
Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
06:00am, Tuesday, 07'th May 2024
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference.
Aurinia Pharma: A Welcome Change To The Thesis (Rating Upgrade)
04:49pm, Thursday, 02'nd May 2024
AUPH reports Q1'24 net product revenues of $48.1M, representing a 13.6% increase from the previous quarter. AUPH's pipeline member AUR200 has not been shelved and could enter phase 1 studies in 2024 w
Aurinia Pharmaceuticals Inc. (AUPH) Q1 2024 Earnings Call Transcript
12:03pm, Thursday, 02'nd May 2024
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH ) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Andrea Christopher - Head, Corporate Communications & Investor Relations Peter
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
08:11am, Thursday, 02'nd May 2024
Aurinia Pharmaceuticals (AUPH) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.18 per share a year ago.
